Financhill
Sell
35

MMM Quote, Financials, Valuation and Earnings

Last price:
$129.24
Seasonality move :
1.43%
Day range:
$125.75 - $130.35
52-week range:
$88.23 - $141.34
Dividend yield:
2.79%
P/E ratio:
16.32x
P/S ratio:
2.07x
P/B ratio:
15.17x
Volume:
8.3M
Avg. volume:
3.1M
1-year change:
49.15%
Market cap:
$70.4B
Revenue:
$32.7B
EPS (TTM):
$7.92
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $32.1B $32.2B $35.4B $34.2B $32.7B
Revenue Growth (YoY) -1.92% 0.15% 9.85% -3.19% -4.52%
 
Cost of Revenues $17.1B $16.6B $18.8B $19.2B $18.5B
Gross Profit $15B $15.6B $16.6B $15B $14.2B
Gross Profit Margin 46.68% 48.41% 46.84% 43.81% 43.46%
 
R&D Expenses $1.9B $1.9B $2B $1.9B $1.8B
Selling, General & Admin $7B $6.9B $7.2B $9B $21.5B
Other Inc / (Exp) -$49M $523M $297M $2.7B $165M
Operating Expenses $8.9B $8.8B $9.2B $10.9B $23.4B
Operating Income $6.1B $6.8B $7.4B $4.1B -$9.2B
 
Net Interest Expenses $368M $500M $462M $395M $689M
EBT. Incl. Unusual Items $5.6B $6.8B $7.2B $6.4B -$9.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1B $1.3B $1.3B $612M -$2.7B
Net Income to Company $4.5B $5.5B $5.9B $5.8B -$7B
 
Minority Interest in Earnings -$12M -$4M -$8M -$14M -$16M
Net Income to Common Excl Extra Items $4.5B $5.4B $5.9B $5.8B -$7B
 
Basic EPS (Cont. Ops) $7.83 $9.43 $10.23 $10.21 -$12.63
Diluted EPS (Cont. Ops) $7.72 $9.36 $10.12 $10.18 -$12.63
Weighted Average Basic Share $577M $577.6M $579M $566M $553.9M
Weighted Average Diluted Share $585.1M $582.2M $585.3M $567.6M $553.9M
 
EBITDA $7.7B $9.2B $9.6B $8.7B -$6.8B
EBIT $6.1B $7.3B $7.7B $6.9B -$8.7B
 
Revenue (Reported) $32.1B $32.2B $35.4B $34.2B $32.7B
Operating Income (Reported) $6.1B $6.8B $7.4B $4.1B -$9.2B
Operating Income (Adjusted) $6.1B $7.3B $7.7B $6.9B -$8.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $8.4B $8.9B $8.6B $6.3B $6.3B
Revenue Growth (YoY) 4.49% 7.09% -3.61% -27.25% 0.38%
 
Cost of Revenues $4.3B $4.9B $4.7B $3.7B $3.6B
Gross Profit $4B $4.1B $3.9B $2.6B $2.6B
Gross Profit Margin 48.47% 45.73% 45.14% 40.73% 42.06%
 
R&D Expenses $461M $482M $461M $267M $269M
Selling, General & Admin $1.7B $1.8B $2B $5.4B $1.1B
Other Inc / (Exp) $40M $80M $2.8B $62M $574M
Operating Expenses $2.1B $2.3B $2.5B $5.7B $1.3B
Operating Income $1.9B $1.8B $1.4B -$3.1B $1.3B
 
Net Interest Expenses $123M $111M $89M $232M $169M
EBT. Incl. Unusual Items $1.8B $1.8B $4.1B -$3.3B $1.7B
Earnings of Discontinued Ops. -- -- -- $452M --
Income Tax Expense $391M $324M $271M -$777M $348M
Net Income to Company $1.4B $1.4B $3.9B -$2.1B $1.4B
 
Minority Interest in Earnings -$4M -$3M -$4M -$4M -$4M
Net Income to Common Excl Extra Items $1.4B $1.4B $3.9B -$2.1B $1.4B
 
Basic EPS (Cont. Ops) $2.47 $2.47 $6.79 -$3.74 $2.49
Diluted EPS (Cont. Ops) $2.45 $2.45 $6.77 -$3.74 $2.48
Weighted Average Basic Share $577.8M $579.6M $568.8M $554.3M $550.6M
Weighted Average Diluted Share $582.4M $586.3M $570M $554.3M $552.7M
 
EBITDA $2.4B $2.4B $4.7B -$2.5B $2.3B
EBIT $2B $1.9B $4.2B -$3B $2B
 
Revenue (Reported) $8.4B $8.9B $8.6B $6.3B $6.3B
Operating Income (Reported) $1.9B $1.8B $1.4B -$3.1B $1.3B
Operating Income (Adjusted) $2B $1.9B $4.2B -$3B $2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $31.7B $35.3B $34.8B $28.7B $34.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.5B $18.5B $19.3B $16.6B $18.8B
Gross Profit $15.2B $16.8B $15.4B $12B $15.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.9B $2B $1.9B $1.5B $2B
Selling, General & Admin $7B $7.3B $8.7B $20.9B $7.3B
Other Inc / (Exp) $431M $257M $3B -$104M $954M
Operating Expenses $8.9B $9.2B $10.6B $22.4B $9.2B
Operating Income $6.2B $7.6B $4.8B -$10.3B $6.5B
 
Net Interest Expenses $472M $488M $421M $496M $901M
EBT. Incl. Unusual Items $6.2B $7.4B $7.4B -$10.9B $6.6B
Earnings of Discontinued Ops. -- -- -- $782M -$59M
Income Tax Expense $1.2B $1.4B $777M -$2.8B $1.1B
Net Income to Company $5B $6B $6.6B -$7.4B $4.4B
 
Minority Interest in Earnings -$4M -$8M -$13M -$16M -$17M
Net Income to Common Excl Extra Items $5B $6B $6.6B -$7.4B $4.4B
 
Basic EPS (Cont. Ops) $8.68 $10.29 $11.53 -$13.34 $7.93
Diluted EPS (Cont. Ops) $8.61 $10.19 $11.48 -$13.35 $7.92
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $8.6B $9.8B $9.7B -$8.4B $9.5B
EBIT $6.7B $7.9B $7.8B -$10.3B $8B
 
Revenue (Reported) $31.7B $35.3B $34.8B $28.7B $34.6B
Operating Income (Reported) $6.2B $7.6B $4.8B -$10.3B $6.5B
Operating Income (Adjusted) $6.7B $7.9B $7.8B -$10.3B $8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $23.6B $26.7B $26.2B $20.6B $20.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.2B $14.1B $14.6B $12.1B $11.5B
Gross Profit $11.4B $12.6B $11.5B $8.5B $9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.4B $1.5B $1.4B $1B $986M
Selling, General & Admin $5B $5.4B $6.9B $18.7B $3.9B
Other Inc / (Exp) $505M $239M $2.9B $118M $902M
Operating Expenses $6.5B $6.9B $8.3B $19.8B $4.9B
Operating Income $4.9B $5.8B $3.2B -$11.2B $4.1B
 
Net Interest Expenses $364M $352M $311M $412M $623M
EBT. Incl. Unusual Items $5.1B $5.6B $5.8B -$11.5B $4.4B
Earnings of Discontinued Ops. -- -- -- $782M -$59M
Income Tax Expense $1B $1.1B $550M -$2.8B $856M
Net Income to Company $4B $4.6B $5.2B -$7.9B $3.5B
 
Minority Interest in Earnings -$3M -$7M -$12M -$14M -$15M
Net Income to Common Excl Extra Items $4B $4.6B $5.2B -$7.9B $3.4B
 
Basic EPS (Cont. Ops) $7.00 $7.89 $9.20 -$14.32 $6.23
Diluted EPS (Cont. Ops) $6.95 $7.81 $9.17 -$14.33 $6.22
Weighted Average Basic Share $1.7B $1.7B $1.7B $1.7B $1.7B
Weighted Average Diluted Share $1.7B $1.8B $1.7B $1.7B $1.7B
 
EBITDA $6.9B $7.4B $7.5B -$9.5B $6.4B
EBIT $5.5B $6B $6.1B -$11B $5.4B
 
Revenue (Reported) $23.6B $26.7B $26.2B $20.6B $20.6B
Operating Income (Reported) $4.9B $5.8B $3.2B -$11.2B $4.1B
Operating Income (Adjusted) $5.5B $6B $6.1B -$11B $5.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2.4B $4.6B $4.6B $3.7B $5.9B
Short Term Investments $98M $404M $201M $238M $53M
Accounts Receivable, Net $4.8B $4.7B $4.7B $4.5B $4.8B
Inventory $4.1B $4.2B $5B $5.4B $4.8B
Prepaid Expenses $704M $675M $654M $435M $485M
Other Current Assets $174M $166M $151M $191M $149M
Total Current Assets $13B $15B $15.4B $14.7B $16.4B
 
Property Plant And Equipment $10.2B $10.3B $10.3B $10B $9.9B
Long-Term Investments $196M $214M $262M $967M $244M
Goodwill $13.4B $13.8B $13.5B $12.8B $12.9B
Other Intangibles $6.4B $5.8B $5.3B $4.7B $4.2B
Other Long-Term Assets $660M $676M $771M $1B $682M
Total Assets $44.7B $47.3B $47.1B $46.5B $50.6B
 
Accounts Payable $2.2B $2.6B $3B $3.2B $3.2B
Accrued Expenses $1.3B $1.4B $1.8B $1.4B $1.7B
Current Portion Of Long-Term Debt $1.8B $806M $1.3B $1.9B $1.2B
Current Portion Of Capital Lease Obligations $247M $256M $263M $261M $225M
Other Current Liabilities $1.5B $1.6B $1.3B $1.4B $5.7B
Total Current Liabilities $9.2B $7.9B $9B $9.5B $15.3B
 
Long-Term Debt $17.5B $18B $16.1B $14B $13.1B
Capital Leases -- -- -- -- --
Total Liabilities $34.5B $34.4B $32B $31.7B $45.7B
 
Common Stock $9M $9M $9M $9M $9M
Other Common Equity Adj -$8.1B -$7.7B -$6.8B -$6.7B -$6.8B
Common Equity $10.1B $12.9B $15B $14.7B $4.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $63M $64M $71M $48M $61M
Total Equity $10.1B $12.9B $15.1B $14.8B $4.9B
 
Total Liabilities and Equity $44.7B $47.3B $47.1B $46.5B $50.6B
Cash and Short Terms $2.5B $5B $4.8B $3.9B $6B
Total Debt $20.3B $18.8B $17.4B $15.9B $16B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $4.1B $4.9B $3.4B $5.1B $6.1B
Short Term Investments $440M $855M $185M $73M $1.2B
Accounts Receivable, Net $4.6B $4.9B $4.7B $4.9B $3.5B
Inventory $4B $5B $5.6B $5.1B $4B
Prepaid Expenses $516M $501M $467M $578M $470M
Other Current Assets $426M $326M $502M $490M $967M
Total Current Assets $14.1B $16.4B $14.9B $16.2B $16.3B
 
Property Plant And Equipment $10.1B $10.2B $10B $9.8B $8.1B
Long-Term Investments -- -- -- -- --
Goodwill $13.5B $13.6B $12.7B $12.7B $6.4B
Other Intangibles $5.9B $5.4B $4.8B $4.3B $1.2B
Other Long-Term Assets $1.8B $2.7B $3.8B $6.6B $8.8B
Total Assets $45.4B $48.3B $46.2B $49.6B $40.9B
 
Accounts Payable $2.2B $2.9B $3.1B $3.1B $2.7B
Accrued Expenses $721M $1B $717M $905M $703M
Current Portion Of Long-Term Debt $1.2B $2B $1.9B $3.1B $1.9B
Current Portion Of Capital Lease Obligations $252M $262M $241M $234M $168M
Other Current Liabilities $2.8B $3.2B $3.4B $7.9B $5.5B
Total Current Liabilities $7.4B $9.6B $9.5B $15.5B $11.4B
 
Long-Term Debt $18.4B $16.2B $13.8B $12.9B $11.3B
Capital Leases -- -- -- -- --
Total Liabilities $33.4B $33.7B $32B $44.9B $36.2B
 
Common Stock $9M $9M $9M $9M $9M
Other Common Equity Adj -$8B -$7.6B -$8B -$6.7B -$5.2B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $63M $70M $76M $59M $52M
Total Equity $11.9B $14.5B $14.2B $4.7B $4.7B
 
Total Liabilities and Equity $45.4B $48.3B $46.2B $49.6B $40.9B
Cash and Short Terms $4.6B $5.7B $3.6B $5.2B $7.3B
Total Debt $19.6B $18.2B $15.7B $16B $13.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $4.5B $5.5B $5.9B $5.8B -$7B
Depreciation & Amoritzation $1.6B $1.9B $1.9B $1.8B $2B
Stock-Based Compensation $278M $262M $274M $263M $274M
Change in Accounts Receivable $345M $165M -$122M -$105M -$170M
Change in Inventories $370M -$91M -$903M -$629M $567M
Cash From Operations $7.1B $8.1B $7.5B $5.6B $6.7B
 
Capital Expenditures $1.7B $1.5B $1.6B $1.7B $1.6B
Cash Acquisitions -$4.7B $551M -- $491M $60M
Cash From Investing -$6.4B -$580M -$1.3B -$1B -$1.2B
 
Dividends Paid (Ex Special Dividend) -$3.3B -$3.4B -$3.4B -$3.4B -$3.3B
Special Dividend Paid
Long-Term Debt Issued $6.3B $1.8B $1M $1M $2.8B
Long-Term Debt Repaid -$2.7B -$3.5B -$1.1B -$1.2B -$3.1B
Repurchase of Common Stock -$1.4B -$368M -$2.2B -$1.5B -$33M
Other Financing Activities -$197M -$98M -$20M -$60M -$21M
Cash From Financing -$1.1B -$5.3B -$6.1B -$5.4B -$3.1B
 
Beginning Cash (CF) $2.9B $2.4B $4.6B $4.6B $3.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$498M $2.2B -$8M -$805M $2.3B
Ending Cash (CF) $2.4B $4.6B $4.6B $3.7B $5.9B
 
Levered Free Cash Flow $5.4B $6.6B $5.9B $3.8B $5.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.4B $1.4B $3.9B -$2.1B $1.4B
Depreciation & Amoritzation $481M $476M $450M $535M $310M
Stock-Based Compensation $44M $43M $44M $46M $42M
Change in Accounts Receivable -$128M $13M -$10M $22M $132M
Change in Inventories $241M -$179M -$181M $135M $98M
Cash From Operations $2.5B $1.9B $1.5B $1.9B -$1.8B
 
Capital Expenditures $368M $343M $435M $405M $246M
Cash Acquisitions $3M -- $478M $60M --
Cash From Investing -$523M -$389M $156M -$287M -$1.2B
 
Dividends Paid (Ex Special Dividend) -$847M -$856M -$850M -$828M -$383M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $904M --
Long-Term Debt Repaid -$1.3B -- -- -$632M --
Repurchase of Common Stock -- -$527M -$155M -$2M -$675M
Other Financing Activities -$2M -$2M -$7M -$7M -$65M
Cash From Financing -$2.1B -$1.3B -$933M -$704M -$1.1B
 
Beginning Cash (CF) $4.2B $4.7B $2.7B $4.3B $10.1B
Foreign Exchange Rate Adjustment $42M -$3M -$72M -$37M $43M
Additions / Reductions -$140M $186M $754M $919M -$4.1B
Ending Cash (CF) $4.1B $4.9B $3.4B $5.1B $6.1B
 
Levered Free Cash Flow $2.1B $1.5B $1.1B $1.5B -$2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $5B $6B $6.6B -$7.4B $4.4B
Depreciation & Amoritzation $1.9B $1.9B $1.9B $1.9B $1.6B
Stock-Based Compensation $264M $273M $273M $259M $294M
Change in Accounts Receivable $472M -$272M -$265M -$9M $114M
Change in Inventories $158M -$957M -$1.1B $625M $159M
Cash From Operations $7.9B $8B $5.7B $6.6B $2B
 
Capital Expenditures $1.6B $1.5B $1.8B $1.8B $1.2B
Cash Acquisitions -$3.7B -- $491M $60M --
Cash From Investing -$5.6B -$1.7B -$543M -$1.3B -$2.4B
 
Dividends Paid (Ex Special Dividend) -$3.4B -$3.4B -$3.4B -$3.3B -$2.4B
Special Dividend Paid
Long-Term Debt Issued $1.9B $6M $1M $2B $9.2B
Long-Term Debt Repaid -$4.3B -$1.5B -$1.9B -$2.4B -$3.3B
Repurchase of Common Stock -$530M -$1.3B -$1.9B -$567M -$1.1B
Other Financing Activities -$86M -$72M -$28M -$47M -$704M
Cash From Financing -$5.9B -$5.5B -$6.4B -$3.5B $1.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.6B $738M -$1.3B $1.8B $880M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.3B $6.5B $3.9B $4.9B $739M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4B $4.6B $5.2B -$7.9B $3.5B
Depreciation & Amoritzation $1.4B $1.4B $1.4B $1.5B $1B
Stock-Based Compensation $216M $227M $226M $222M $242M
Change in Accounts Receivable $113M -$324M -$467M -$371M -$87M
Change in Inventories $43M -$823M -$1B $236M -$172M
Cash From Operations $5.6B $5.4B $3.7B $4.7B $1M
 
Capital Expenditures $1.1B $1B $1.2B $1.3B $890M
Cash Acquisitions $551M -- $491M $60M --
Cash From Investing -$321M -$1.4B -$658M -$906M -$2.1B
 
Dividends Paid (Ex Special Dividend) -$2.5B -$2.6B -$2.6B -$2.5B -$1.6B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.7B $1M $1M $2B $8.4B
Long-Term Debt Repaid -$2.5B -$450M -$1.2B -$2.4B -$2.7B
Repurchase of Common Stock -$366M -$1.3B -$928M -$31M -$1.1B
Other Financing Activities -$47M -$21M -$29M -$16M -$699M
Cash From Financing -$3.5B -$3.7B -$4B -$2.2B $2.2B
 
Beginning Cash (CF) $10.8B $14B $10.5B $11.7B $26.9B
Foreign Exchange Rate Adjustment -$11M -$40M -$136M -$80M -$2M
Additions / Reductions $1.8B $284M -$1B $1.6B $119M
Ending Cash (CF) $12.6B $14.2B $9.4B $13.2B $27B
 
Levered Free Cash Flow $4.5B $4.4B $2.4B $3.4B -$889M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock